Advanced Medical Solutions GroupCHIX:AMSL +14.17%93 Interest Coverage is 6.76 as of Dec. 2025, which is 89% below its 10-year median of 59.71. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.71 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks worse than 72.86% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Advanced Medical Solutions Group's
Operating Income
for the
six
months ended in Dec. 2025 was £14.8 Mil. Advanced Medical Solutions Group's Interest Expense for the
six
months ended in Dec. 2025 was £-2.2 Mil.
Advanced Medical Solutions Group's interest coverage for the quarter that ended in Dec. 2025 was 6.76.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Advanced Medical Solutions Group's Interest Coverage or its related term are showing as below:
CHIX:AMSl'
s Interest Coverage Range Over the Past 10 Years
Min: 5.93 Med: 59.71 Max: 229.45
Current: 5.93
CHIX:AMSl's Interest Coverage is ranked worse than 72.86% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs CHIX:AMSl: 5.93
Advanced Medical Solutions Group (CHIX:AMSl) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Advanced Medical Solutions Group Interest Coverage Related Terms
Advanced Medical Solutions Group Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Advanced Medical Solutions Group Interest Coverage Chart
CHIX:AMSL vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's Interest Coverage falls into.
Advanced Medical Solutions Group Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group (CHIX:AMSL) has a Interest Coverage of 6.76 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Advanced Medical Solutions Group and its competitors. This is 89% below median its historical median of 59.71. Over the past decade, Advanced Medical Solutions Group's Interest Coverage has ranged from 5.93 to 229.45. According to the industry distribution chart, Advanced Medical Solutions Group ranks #341 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 72.9%.
Is Advanced Medical Solutions Group's Interest Coverage too high?
Advanced Medical Solutions Group's current Interest Coverage of 6.76 is 89% below median its 10-year median of 59.71. Over the past 10 years, this metric has ranged from a low of 5.93 to a high of 229.45. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Advanced Medical Solutions Group's value of 6.76 is 57% below this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #341 out of 468 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #341 out of 468 companies for Interest Coverage. This places Advanced Medical Solutions Group in the lower half of its industry. The industry median Interest Coverage is 15.71. Advanced Medical Solutions Group's value of 6.76 is 57% below this benchmark. Historically, Advanced Medical Solutions Group's own Interest Coverage has ranged from 5.93 to 229.45 over the past decade. While the company's 10-year median is 59.71 vs. the industry median of 15.71, Advanced Medical Solutions Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current Interest Coverage of 6.76 is 57% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Interest Coverage is 6.76, which is 89% below median its own 10-year median of 59.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.71, compared to a current price of £2.78 — trading 25.1% below its estimated fair value. The current Interest Coverage is 6.76, which is 89% below median its 10-year median of 59.71 and 57% below the Medical Devices & Instruments industry median of 15.71. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Interest Coverage is 6.76 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.78 is trading 25.1% below its estimated GF Value™ of £3.71.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
Interest Coverage: 6.76 (89% below median its 10-year median of 59.71)
GF Value™: £3.71 vs. price of £2.78 (25.1% below fair value)
Industry Position: 57% below the Medical Devices & Instruments median (#341 of 468)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
